Innate Pharma develops drugs for treatment of cancer and inflammatory diseases. Innate Pharma primarily focuses on the development of new therapeutic solutions and monoclonal antibodies for the treatment of cancer, as well as for the treatment of infectious diseases and chronic inflammatory pathologies. The Company is developing two categories of immunotherapies: immuno-modulators and cytotoxic antibodies.